Itch-X Shortage: What Providers and Prescribers Need to Know in 2026

Patients presenting with insect bites, poison ivy rashes, sunburns, and minor skin irritations have long turned to Itch-X (pramoxine HCl 1% / benzyl alcohol 10%) for fast, steroid-free topical relief. In 2026, however, many patients are finding it increasingly difficult to locate at their usual pharmacy. As a provider, understanding the availability landscape — and knowing what to recommend when Itch-X is unavailable — will help you give better guidance at point of care.

Clinical Background: What Is Itch-X?

Itch-X is an OTC topical combination product manufactured by B.F. Ascher & Company. Its active ingredients are:

Pramoxine HCl 1%: A topical local anesthetic. Pramoxine stabilizes neuronal membranes, blocking the generation and conduction of nerve impulses by reducing sodium permeability and increasing action potential threshold. It is chemically distinct from other local anesthetics (not an aminoester or aminoamide) and is less likely to trigger cross-sensitivity reactions.

Benzyl alcohol 10%: A topical analgesic that provides additional pain and itch relief. Also has some antimicrobial properties.

The formulation also contains aloe vera, which provides soothing properties. Itch-X is available as a gel (1.25 oz tube) and spray. It is FDA-regulated as an OTC product and does not require a prescription.

Availability Status in 2026

Itch-X is not listed on the FDA Drug Shortage Database. This is an OTC product, and most OTC supply disruptions do not appear in FDA shortage reporting. In practice, however, patients are reporting localized and regional stockouts at major pharmacy chains. Contributing factors include:

Limited retail distribution from a specialty manufacturer

Retailer decisions to reduce shelf space for specialty OTC brands

Seasonal demand spikes during spring and summer months

Clinical Alternatives for Providers to Recommend

When counseling patients who cannot access Itch-X, the following alternatives cover the same clinical territory:

Pramoxine HCl 1% alternatives (same active): CeraVe Itch Relief Moisturizing Cream, Sarna Sensitive Anti-Itch Lotion, Aveeno Anti-Itch Concentrated Lotion, Gold Bond Medicated Anti-Itch Lotion. These are more widely distributed and provide equivalent pramoxine-mediated analgesia.

Hydrocortisone 1% (for inflammation-driven itch): Appropriate for contact dermatitis, eczema, and insect bites with significant inflammatory component. Advise patients to limit use to 7 days per area per OTC labeling.

Diphenhydramine 2% cream: For histamine-mediated itch (urticaria, allergic reactions). Caution against use over large body surface areas due to potential systemic absorption.

Calamine lotion: Appropriate for weeping dermatoses (poison ivy, chickenpox), safe for pediatric use, and widely available.

Important Note on Pramoxine Cross-Sensitivity

Pramoxine is structurally distinct from aminoester anesthetics (like procaine, benzocaine) and aminoamide anesthetics (like lidocaine, bupivacaine). Patients with reported hypersensitivity to those classes can often tolerate pramoxine without cross-reactivity. This makes pramoxine-based products a useful option when patients have anesthetic allergies. However, patch testing or clinical caution is appropriate for any patient with a history of multiple topical anesthetic reactions.

How to Help Your Patients Find Itch-X

Rather than sending your patient to call pharmacy after pharmacy, consider directing them to medfinder. medfinder calls local pharmacies on behalf of patients to check which ones have the medication in stock. The patient receives a text with the results, dramatically reducing the time spent searching. This is especially helpful for older patients, patients managing chronic conditions, or those without easy access to the internet.

Documentation and Prescribing Considerations

Itch-X and its generic equivalents do not require a prescription. However, if a patient needs a written recommendation for an FSA/HSA reimbursement or a letter of medical necessity for insurance purposes, note that pramoxine HCl / benzyl alcohol topical gel is the generic formulation, and that clinically equivalent alternatives include pramoxine HCl 1% products.

For a step-by-step guide on how to assist your patients in locating Itch-X, see our companion article: How to Help Your Patients Find Itch-X in Stock.